Article Versions Notes

Herrera F, Torres D, Laborde A, Berruezo L, Jordán R, Rossi IR, Valledor A, Costantini P, Dictar M, Nenna A, et al. Development of a Clinical Score to Stratify the Risk for Carbapenem-Resistant Enterobacterales Bacteremia in Patients with Cancer and Hematopoietic Stem Cell Transplantation. Antibiotics. 2023; 12(2):226. https://doi.org/10.3390/antibiotics12020226

Herrera, Fabián, Diego Torres, Ana Laborde, Lorena Berruezo, Rosana Jordán, Inés Roccia Rossi, Alejandra Valledor, Patricia Costantini, Miguel Dictar, Andrea Nenna, and et al. 2023. "Development of a Clinical Score to Stratify the Risk for Carbapenem-Resistant Enterobacterales Bacteremia in Patients with Cancer and Hematopoietic Stem Cell Transplantation" Antibiotics 12, no. 2: 226. https://doi.org/10.3390/antibiotics12020226

Herrera, F., Torres, D., Laborde, A., Berruezo, L., Jordán, R., Rossi, I. R., Valledor, A., Costantini, P., Dictar, M., Nenna, A., Pereyra, M. L., Lambert, S., Benso, J., Poletta, F., Gonzalez Ibañez, M. L., Baldoni, N., Eusebio, M. J., Lovano, F., Barcán, L., ... Carena, A. Á., on behalf of the Argentine Group for the Study of Bacteremia in Cancer and Stem Cell Transplant (ROCAS) Study. (2023). Development of a Clinical Score to Stratify the Risk for Carbapenem-Resistant Enterobacterales Bacteremia in Patients with Cancer and Hematopoietic Stem Cell Transplantation. Antibiotics, 12(2), 226. https://doi.org/10.3390/antibiotics12020226